Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

pLenti PGK V5-LUC Neo (w623-2) Citations (27)

Originally described in: A Versatile Viral System for Expression and Depletion of Proteins in Mammalian Cells
Campeau E, Ruhl VE, Rodier F, Smith CL, Rahmberg BL, Fuss JO, Campisi J, Yaswen P, Cooper PK, Kaufman PD. PLoS One. 2009 Aug 6;4(8):e6529.
PubMed Journal

Articles Citing pLenti PGK V5-LUC Neo (w623-2)

Articles
Heat shock factor-1 knockout induces multidrug resistance gene, MDR1b, and enhances P-glycoprotein (ABCB1)-based drug extrusion in the heart. Krishnamurthy K, Vedam K, Kanagasabai R, Druhan LJ, Ilangovan G. Proc Natl Acad Sci U S A. 2012 Jun 5;109(23):9023-8. doi: 10.1073/pnas.1200731109. Epub 2012 May 21. PubMed
Multimodal cell tracking of a spontaneous metastasis model: comparison between MRI, electron paramagnetic resonance and bioluminescence. Danhier P, De Preter G, Magat J, Godechal Q, Porporato PE, Jordan BF, Feron O, Sonveaux P, Gallez B. Contrast Media Mol Imaging. 2014 Mar-Apr;9(2):143-53. doi: 10.1002/cmmi.1553. PubMed
The histone demethylase KDM4B regulates peritoneal seeding of ovarian cancer. Wilson C, Qiu L, Hong Y, Karnik T, Tadros G, Mau B, Ma T, Mu Y, New J, Louie RJ, Gunewardena S, Godwin AK, Tawfik OW, Chien J, Roby KF, Krieg AJ. Oncogene. 2016 Nov 21. doi: 10.1038/onc.2016.412. PubMed
Inactivation of Capicua drives cancer metastasis. Okimoto RA, Breitenbuecher F, Olivas VR, Wu W, Gini B, Hofree M, Asthana S, Hrustanovic G, Flanagan J, Tulpule A, Blakely CM, Haringsma HJ, Simmons AD, Gowen K, Suh J, Miller VA, Ali S, Schuler M, Bivona TG. Nat Genet. 2017 Jan;49(1):87-96. doi: 10.1038/ng.3728. Epub 2016 Nov 21. PubMed
Loss of RasGAP Tumor Suppressors Underlies the Aggressive Nature of Luminal B Breast Cancers. Olsen SN, Wronski A, Castano Z, Dake B, Malone C, De Raedt T, Enos M, DeRose YS, Zhou W, Guerra S, Loda M, Welm A, Partridge AH, McAllister SS, Kuperwasser C, Cichowski K. Cancer Discov. 2017 Feb;7(2):202-217. doi: 10.1158/2159-8290.CD-16-0520. Epub 2016 Dec 14. PubMed
An FAK-YAP-mTOR Signaling Axis Regulates Stem Cell-Based Tissue Renewal in Mice. Hu JK, Du W, Shelton SJ, Oldham MC, DiPersio CM, Klein OD. Cell Stem Cell. 2017 Jul 6;21(1):91-106.e6. doi: 10.1016/j.stem.2017.03.023. Epub 2017 Apr 27. PubMed
Combination Therapy with c-Met and Src Inhibitors Induces Caspase-Dependent Apoptosis of Merlin-Deficient Schwann Cells and Suppresses Growth of Schwannoma Cells. Fuse MA, Plati SK, Burns SS, Dinh CT, Bracho O, Yan D, Mittal R, Shen R, Soulakova JN, Copik AJ, Liu XZ, Telischi FF, Chang LS, Franco MC, Fernandez-Valle C. Mol Cancer Ther. 2017 Nov;16(11):2387-2398. doi: 10.1158/1535-7163.MCT-17-0417. Epub 2017 Aug 3. PubMed
Monocarboxylate Transporter MCT1 Promotes Tumor Metastasis Independently of Its Activity as a Lactate Transporter. Payen VL, Hsu MY, Radecke KS, Wyart E, Vazeille T, Bouzin C, Porporato PE, Sonveaux P. Cancer Res. 2017 Oct 15;77(20):5591-5601. doi: 10.1158/0008-5472.CAN-17-0764. Epub 2017 Aug 21. PubMed
Fascin Controls Metastatic Colonization and Mitochondrial Oxidative Phosphorylation by Remodeling Mitochondrial Actin Filaments. Lin S, Huang C, Gunda V, Sun J, Chellappan SP, Li Z, Izumi V, Fang B, Koomen J, Singh PK, Hao J, Yang S. Cell Rep. 2019 Sep 10;28(11):2824-2836.e8. doi: 10.1016/j.celrep.2019.08.011. PubMed
Identification of FUBP1 as a Long Tail Cancer Driver and Widespread Regulator of Tumor Suppressor and Oncogene Alternative Splicing. Elman JS, Ni TK, Mengwasser KE, Jin D, Wronski A, Elledge SJ, Kuperwasser C. Cell Rep. 2019 Sep 24;28(13):3435-3449.e5. doi: 10.1016/j.celrep.2019.08.060. PubMed
ATR addiction in multiple myeloma: synthetic lethal approaches exploiting established therapies. Botrugno OA, Bianchessi S, Zambroni D, Frenquelli M, Belloni D, Bongiovanni L, Girlanda S, Di Terlizzi S, Ferrarini M, Ferrero E, Ponzoni M, Marcatti M, Tonon G. Haematologica. 2019 Nov 14. pii: haematol.2018.215210. doi: 10.3324/haematol.2018.215210. PubMed
CX3CR1-CD8+ T cells are critical in antitumor efficacy but functionally suppressed in the tumor microenvironment. Yamauchi T, Hoki T, Oba T, Saito H, Attwood K, Sabel MS, Chang AE, Odunsi K, Ito F. JCI Insight. 2020 Apr 23;5(8). pii: 133920. doi: 10.1172/jci.insight.133920. PubMed
Use of a Luciferase-Expressing Orthotopic Rat Brain Tumor Model to Optimize a Targeted Irradiation Strategy for Efficacy Testing with Temozolomide. Mowday AM, Lieuwes NG, Biemans R, Marcus D, Rezaeifar B, Reniers B, Verhaegen F, Theys J, Dubois LJ. Cancers (Basel). 2020 Jun 15;12(6). pii: cancers12061585. doi: 10.3390/cancers12061585. PubMed
Overcoming primary and acquired resistance to anti-PD-L1 therapy by induction and activation of tumor-residing cDC1s. Oba T, Long MD, Keler T, Marsh HC, Minderman H, Abrams SI, Liu S, Ito F. Nat Commun. 2020 Oct 27;11(1):5415. doi: 10.1038/s41467-020-19192-z. PubMed
CXCR4 engagement triggers CD47 internalization and antitumor immunization in a mouse model of mesothelioma. Mezzapelle R, De Marchis F, Passera C, Leo M, Brambilla F, Colombo F, Casalgrandi M, Preti A, Zambrano S, Castellani P, Ertassi R, Silingardi M, Caprioglio F, Basso V, Boldorini R, Carretta A, Sanvito F, Rena O, Rubartelli A, Sabatino L, Mondino A, Crippa MP, Colantuoni V, Bianchi ME. EMBO Mol Med. 2021 Jun 7;13(6):e12344. doi: 10.15252/emmm.202012344. Epub 2021 May 6. PubMed
Short lifespan of syngeneic transplanted MSC is a consequence of in vivo apoptosis and immune cell recruitment in mice. Preda MB, Neculachi CA, Fenyo IM, Vacaru AM, Publik MA, Simionescu M, Burlacu A. Cell Death Dis. 2021 Jun 2;12(6):566. doi: 10.1038/s41419-021-03839-w. PubMed
The novel long noncoding RNA AU021063, induced by IL-6/Arid5a signaling, exacerbates breast cancer invasion and metastasis by stabilizing Trib3 and activating the Mek/Erk pathway. Nyati KK, Hashimoto S, Singh SK, Tekguc M, Metwally H, Liu YC, Okuzaki D, Gemechu Y, Kang S, Kishimoto T. Cancer Lett. 2021 Nov 1;520:295-306. doi: 10.1016/j.canlet.2021.08.004. Epub 2021 Aug 10. PubMed
Neoadjuvant In Situ Immunomodulation Enhances Systemic Antitumor Immunity against Highly Metastatic Tumors. Oba T, Kajihara R, Yokoi T, Repasky EA, Ito F. Cancer Res. 2021 Dec 15;81(24):6183-6195. doi: 10.1158/0008-5472.CAN-21-0939. Epub 2021 Oct 19. PubMed
Local, multimodal intralesional therapy renders distant brain metastases susceptible to PD-L1 blockade in a preclinical model of triple-negative breast cancer. Yokoi T, Oba T, Kajihara R, Abrams SI, Ito F. Sci Rep. 2021 Nov 9;11(1):21992. doi: 10.1038/s41598-021-01455-4. PubMed
A Novel RGD-4C-Saporin Conjugate Inhibits Tumor Growth in Mouse Models of Bladder Cancer. Zuppone S, Assalini C, Minici C, Botrugno OA, Curnis F, Degano M, Corti A, Montorsi F, Salonia A, Vago R. Front Oncol. 2022 Apr 11;12:846958. doi: 10.3389/fonc.2022.846958. eCollection 2022. PubMed
miRNA-34c Suppresses Osteosarcoma Progression In Vivo by Targeting Notch and E2F. Bae Y, Zeng HC, Chen YT, Ketkar S, Munivez E, Yu Z, Gannon FH, Lee BH. JBMR Plus. 2022 Apr 9;6(5):e10623. doi: 10.1002/jbm4.10623. eCollection 2022 May. PubMed
Longitudinal bioluminescence imaging to monitor breast tumor growth and treatment response using the chick chorioallantoic membrane model. Javed S, Soukhtehzari S, Fernandes N, Williams KC. Sci Rep. 2022 Oct 13;12(1):17192. doi: 10.1038/s41598-022-20854-9. PubMed
BRCA1 mediates protein homeostasis through the ubiquitination of PERK and IRE1. Hromas R, Srinivasan G, Yang M, Jaiswal A, Totterdale TA, Phillips L, Kirby A, Khodayari N, Brantley M, Williamson EA, Kong KY. iScience. 2022 Nov 19;25(12):105626. doi: 10.1016/j.isci.2022.105626. eCollection 2022 Dec 22. PubMed
PTPN11 Mosaicism Causes a Spectrum of Pigmentary and Vascular Neurocutaneous Disorders and Predisposes to Melanoma. Polubothu S, Bender N, Muthiah S, Zecchin D, Demetriou C, Martin SB, Malhotra S, Travnickova J, Zeng Z, Bohm M, Barbarot S, Cottrell C, Davies O, Baselga E, Burrows NP, Carmignac V, Diaz JS, Fink C, Haenssle HA, Happle R, Harland M, Majerowski J, Vabres P, Vincent M, Newton-Bishop JA, Bishop DT, Siegel D, Patton EE, Topf M, Rajan N, Drolet B, Kinsler VA. J Invest Dermatol. 2022 Dec 23:S0022-202X(22)02891-3. doi: 10.1016/j.jid.2022.09.661. PubMed
Antimicrobial peptides CS-piscidin-induced cell death involves activation of RIPK1/PARP, and modification with myristic acid enhances its stability and tumor-targeting capability. Li N, Jiang X, Ma X, Qiu X, Chang H, Qiao Y, Luo H, Zhang Q. Discov Oncol. 2023 Mar 31;14(1):38. doi: 10.1007/s12672-023-00642-1. PubMed
Treating colorectal peritoneal metastases with an injectable cytostatic loaded supramolecular hydrogel in a rodent animal model. Wintjens AGWE, Liu H, Fransen PKH, Lenaerts K, van Almen GC, Gijbels MJ, Hadfoune M, Boonen BTC, Lieuwes NG, Biemans R, Dubois LJ, Dankers PYW, de Hingh IHJT, Bouvy ND. Clin Exp Metastasis. 2023 Jun;40(3):243-253. doi: 10.1007/s10585-023-10210-0. Epub 2023 May 22. PubMed
Revealing and harnessing CD39 for the treatment of colorectal cancer and liver metastases by engineered T cells. Potenza A, Balestrieri C, Spiga M, Albarello L, Pedica F, Manfredi F, Cianciotti BC, De Lalla C, Botrugno OA, Faccani C, Stasi L, Tassi E, Bonfiglio S, Scotti GM, Redegalli M, Biancolini D, Camisa B, Tiziano E, Sirini C, Casucci M, Iozzi C, Abbati D, Simeoni F, Lazarevic D, Elmore U, Fiorentini G, Di Lullo G, Casorati G, Doglioni C, Tonon G, Dellabona P, Rosati R, Aldrighetti L, Ruggiero E, Bonini C. Gut. 2023 Jun 30:gutjnl-2022-328042. doi: 10.1136/gutjnl-2022-328042. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.